Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Dana-Farber Cancer Institute · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
neoplasmspancreatic-cancer
lung cancer squamous cell, solid tumors, head & neck cancer, pancreatic cancer, neoplasms, endometrial cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966551
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.